Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Welcome to the Biofrontera Inc. Third Quarter 2024 Financial ...

The ASX wobbled again on Tuesday, with the S&P/ASX 200 down 0.34 per cent at 1pm, adding to Monday’s 0.4 per cent drop.

The AI-based algorithms showed improved performance with more clinical data, allowing EMVision to proceed with a validation ...

Stéphane Paquette: Good morning, and thank you all for joining today's call. Earlier today, we released our financial results for the third quarter of 2024. The press release is available on our ...

“We are pleased with our second quarter and first half results,” said Dan Carestio, President and CEO of STERIS. “The diversified nature of our business segments continues to prove beneficial to our ...

Obtain regulatory clearance for clinical use ... we have cleared the first stage gate in our clinical product development process and submitted a Q-Sub to the FDA. Specifically, Oncocyte has submitted ...

I’m very impressed and I don’t impress easily,” wrote a customer of the fanatically-reviewed set that’s 40% off right now.

Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 (OX2R) agonist, in acutely ...

Vivani Medical, Inc. ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, long-acting drug implants, today reported financial results for the third quarter ended September ...

Veritone, Inc. (NASDAQ:VERI), a leader in designing human-centered AI solutions, today reported results for the third quarter ended September 30, 2024. "The divestiture ...

Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 (OX2R) agonist, in ...

Check out our top picks from Steam Next Fest October 2024 for an idea of what to expect when the next sale arrives. The best Steam feature for keeping track of sales is your wishlist. Browsing ...